日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Dalpicilib combined with cetuximab in patients with HPV-negative, anti-PD-1-resistant recurrent or metastatic head and neck squamous cell carcinoma: A phase II trial

达匹西利联合西妥昔单抗治疗HPV阴性、抗PD-1耐药的复发性或转移性头颈部鳞状细胞癌患者：一项II期试验

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-026-68736-2
Ju, Houyu; Wu, Yunteng; Shi, Chaoji; Xia, Ronghui; Song, Hao; Ma, Xuhui; Liu, Yang; Sun, Lulu; Zhu, Ling; Chen, Lingyan; Sun, Shuyang; He, Yue; Ren, Guoxin; Hu, Jingzhou
细胞生物学
肿瘤
肿瘤免疫
PD-1
发表日期：2026
文献求助 收藏

Tissue-specific inflammation induces cell state plasticity with oncogenic addiction in mucosal melanoma.

组织特异性炎症诱导细胞状态可塑性，并在粘膜黑色素瘤中产生致癌依赖性。

期刊:Science Advances
影响因子:12.5
doi:10.1126/sciadv.ady4536
Ma Xuhui, Ma Yanni, Zhang Li, Liu Ruixin, Xia Ronghui, Hao Meiling, Song Xiaole, Chen Yinan, Zheng Yang, Wang Hao, Luo Hao, Zheng Shengnan, Yang Jie, Yang Qin, Jiang Ruixin, Chen Xiangyu, Hou Pengcong, Hui Kaiyuan, Bian Qian, Jiang Bin, Jiang Xiaodong, Jiang Min, Zhang Yanjie, Shain A Hunter, Ren Guoxin, Lei Ming, Judson-Torres Robert L, Guo Wei, Zeng Hanlin
黑色素瘤
细胞生物学
Immunology/Inflammation
炎症
发表日期：2026
文献求助 收藏

Neoadjuvant Pembrolizumab Combined with Chemotherapy for Locally Advanced Resectable Oral and Oropharyngeal Squamous Cell Carcinomas: A Single-center Retrospective Study

新辅助帕博利珠单抗联合化疗治疗局部晚期可切除口腔和口咽鳞状细胞癌：一项单中心回顾性研究

期刊:Journal of Cancer
影响因子:3.2
doi:10.7150/jca.122201
Geng, Xinrong; Zhao, Yuanyuan; Wu, Yunteng; Ma, Xuhui; Xia, Ronghui; Xu, Xuanli; Ren, Guoxin
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Epidermal growth factor receptor‑targeted antibody nimotuzumab combined with chemoradiotherapy improves survival in patients with locally advanced head and neck squamous cell carcinoma: a propensity score matching real-world study

表皮生长因子受体靶向抗体尼妥珠单抗联合放化疗可改善局部晚期头颈部鳞状细胞癌患者的生存期：一项倾向评分匹配的真实世界研究

期刊:MedComm
影响因子:10.7
doi:10.1002/mco2.608
Zhang, Peng; Zhang, Xinxin; Lang, Jinyi; Wu, Shaoxiong; Sun, Yan; Wang, Peiguo; Qiu, Sufang; Huang, Xiaodong; Ren, Guoxin; Liu, Kun; Du, Xiaojing; Xiao, Shaowen; Wang, Zhongqiu; Weng, Youliang; Zhang, Ye; Zhou, Hang; Tu, Wenyong; Zhang, Chenping; Yi, Junlin
肿瘤免疫
信号转导
细胞生物学
肿瘤
发表日期：2024
文献求助 收藏

The efficacy and safety of dalpiciclib, a cyclin-dependent kinase 4/6 inhibitor, in patients with advanced head and neck mucosal melanoma harboring CDK4 amplification

达匹西利（一种细胞周期蛋白依赖性激酶 4/6 抑制剂）治疗伴有 CDK4 扩增的晚期头颈部黏膜黑色素瘤患者的疗效和安全性

期刊:BMC Medicine
影响因子:8.3
doi:10.1186/s12916-024-03431-x
Shi, Chaoji; Ju, Houyu; Zhou, Rong; Xu, Shengming; Wu, Yunteng; Gu, Ziyue; Wang, Ying; Chen, Wanling; Huang, Xinyi; Han, Yong; Sun, Shuyang; Li, Chuwen; Wang, Min; Zhou, Guoyu; Zhang, Zhiyuan; Li, Jiang; Ren, Guoxin
黑色素瘤
信号转导
CDK4
细胞生物学
发表日期：2024
文献求助 收藏

The clinical outcome of pembrolizumab for patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a single center, real world study in China

帕博利珠单抗治疗复发或转移性头颈部鳞状细胞癌患者的临床疗效：一项中国单中心真实世界研究

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2024.1360657
Fan, Zongyu; Hui, Rongrong; Ju, Houyu; Wu, Yunteng; Ma, Xuhui; Song, Hao; Liu, Yang; Rui, Mengyu; Geng, Xinrong; Zhao, Minqi; Xin, Yingye; Wei, Dongliang; Ren, Guoxin
细胞生物学
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

The efficacy of cetuximab plus PD-1 inhibitors as salvage therapy in PD-1 refractory patients with recurrent or metastatic head and neck squamous cell carcinoma

西妥昔单抗联合PD-1抑制剂作为PD-1难治性复发或转移性头颈部鳞状细胞癌患者的挽救治疗疗效

期刊:Journal of Cancer
影响因子:3.2
doi:10.7150/jca.92689
Hui, Rongrong; Liu, Xiulan; Fan, Zongyu; Ji, Honghai; Wei, Dongliang; Ren, Guoxin
细胞生物学
肿瘤
肿瘤免疫
PD-1
发表日期：2024
文献求助 收藏

A pilot study of camrelizumab with docetaxel and cisplatin for the first line treatment in recurrent/metastatic oral squamous cell carcinoma

一项关于卡瑞利珠单抗联合多西他赛和顺铂一线治疗复发/转移性口腔鳞状细胞癌的初步研究

期刊:MedComm
影响因子:10.7
doi:10.1002/mco2.312
Ju, Houyu; Wei, Dongliang; Wu, Yunteng; Liu, Yang; Ding, Qi; Rui, Mengyu; Fan, Zongyu; Yao, Yanli; Hu, Jingzhou; Ren, Guoxin
肿瘤免疫
细胞生物学
肿瘤
发表日期：2023
文献求助 收藏

The association between body mass index and efficacy of pembrolizumab as second-line therapy in patients with recurrent/metastatic head and neck squamous cell carcinoma

体重指数与帕博利珠单抗作为二线治疗复发/转移性头颈部鳞状细胞癌患者疗效之间的关联

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.5152
Zhang, Xinyi; Rui, Mengyu; Lin, Chao; Li, Zhi; Wei, Dongliang; Han, Ruxue; Ju, Houyu; Ren, Guoxin
细胞生物学
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Chemotherapy in combination with anti-PD-1 agents as adjuvant therapy for high-risk oral mucosal melanoma

化疗联合抗PD-1药物作为高危口腔黏膜黑色素瘤的辅助治疗

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-022-04090-2
Wu, Yunteng; Wei, Dongliang; Ren, Guoxin; Guo, Wei
黑色素瘤
PD-1
发表日期：2023
文献求助 收藏